tirzepatide to retatrutide vs vs Semaglutide Retatrutide vs Tirzepatide: Technical Research
Description
In trials, Novos Wegovy pill showed 16.6% average weight loss after 64 weeks , versus 12.4% for orforglipron after 72 weeks
doi:10.1016/j.ejphar.2016.04.052 187
Its crucial to remember that these side effects are rare and might not necessarily be linked to the medication
[DOI] [PMC free article] [PubMed] [Google Scholar] 54.Zhou M, et al
Many people experience this pattern at 0.25 mg or 0.5 mg of semaglutide
